Biogenerics and biobetters v/s chemical based drugs - comparative discourse

In search of better drugs in terms of safety and efficacy of biological/biotherapeutics stand apart. The biotherapeutics being a technically innovative product require high intellectual inputs leading to capital expenditure. Biotherapeutics have definitely contributed in terms of efficacy, patient safety and quality of life for patients in terms of chemical based drugs. However, very high cost of manufacturing Biotherapeutics new innovations were initiated to create biogenerics mimicking the line of thought of generics of chemical origin. There are many biogenerics very launched in the market. However, the prices of biogenerics comparable high unlike prices of chemical based drugs. The biogenerics are not the same as the chemical based drugs because of inheritance difference in the structure and the brand innovator. Moreover some of the biogenerics had shown improved activity over the innovator brand are named as Biobetters.